PTSD Checklist 5 (PCL-5)

1. Abstract

The PTSD Checklist for DSM-5 (PCL-5) is an internationally recognized, 20-item self-report rating scale developed to assess the presence and severity of posttraumatic stress disorder (PTSD) symptoms as operationalized by the American Psychiatric Association in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Designed by leading clinical researchers at the National Center for PTSD, the instrument maps directly onto the diagnostic architecture of DSM-5 across four distinct symptom clusters: Criterion B (Intrusion symptoms, items 1–5), Criterion C (Persistent avoidance, items 6–7), Criterion D (Negative alterations in cognitions and mood, items 8–14), and Criterion E (Alterations in arousal and reactivity, items 15–20). Respondents rate how much each symptom has bothered them over the preceding month using a 5-point Likert scale ranging from 0 (“Not at all”) to 4 (“Extremely”), yielding a total symptom severity score between 0 and 80.

Extensive psychometric investigations have established that the PCL-5 possesses exceptional internal consistency, with total scale Cronbach’s alpha coefficients regularly exceeding α = .94 to .96 across military, veteran, civilian, and clinical populations, and individual subscale coefficients ranging from .75 to .90. Test-retest reliability across intervals ranging from one week to thirty days demonstrates strong temporal stability (r = .82 to .88). Construct validity is underscored by robust convergent correlations with clinician-administered structured interviews—most notably the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) (r = .77 to .85)—as well as with validated measures of depression, generalized anxiety, and functional impairment. Discriminant validity is maintained through attenuated associations with unrelated somatic and personality traits. Structural equation modeling and confirmatory factor analysis (CFA) reveal that while the nominal DSM-5 four-factor model demonstrates adequate fit, six-factor anhedonia models and seven-factor hybrid models (incorporating intrusive thoughts, avoidance, negative affect, anhedonia, dysphoric arousal, anxious arousal, and externalizing behaviors) frequently offer superior empirical representation. Widely utilized in epidemiological screening, tertiary psychiatric triage, clinical trials, and longitudinal psychotherapeutic outcome monitoring, the PCL-5 functions as an indispensable psychometric cornerstone in modern traumatic stress research.

2. Keywords

PTSD Checklist for DSM-5, PCL-5, posttraumatic stress disorder, psychometrics, trauma assessment, confirmatory factor analysis, symptom severity, Clinician-Administered PTSD Scale, DSM-5 criteria, internal consistency, screening instrument, clinical outcome monitoring

3. Authors

The PTSD Checklist for DSM-5 was developed by senior investigators at the National Center for PTSD, an operating division within the United States Department of Veterans Affairs. The development team comprised:

• Frank W. Weathers, Ph.D. — Professor Emeritus of Psychology, Auburn University, Auburn, Alabama; Senior Research Consultant, National Center for PTSD.
• Brett T. Litz, Ph.D. — Director, Mental Health Core of the Massachusetts Veterans Epidemiological Research and Information Center (MAVERIC), VA Boston Healthcare System; Professor of Psychiatry and Psychology, Boston University Chobanian & Avedisian School of Medicine.
• Terence M. Keane, Ph.D. — Associate Chief of Staff for Research and Development, VA Boston Healthcare System; Director, Behavioral Science Division, National Center for PTSD; Professor and Vice Chair of Research in Psychiatry, Boston University Chobanian & Avedisian School of Medicine.
• Pamela A. Palmieri, Ph.D. — Senior Research Methodologist and Clinical Psychologist, Summa Health System, Akron, Ohio; formerly Behavioral Science Division, National Center for PTSD.
• Brian P. Marx, Ph.D. — Staff Psychologist, Behavioral Science Division, National Center for PTSD, VA Boston Healthcare System; Professor of Psychiatry, Boston University Chobanian & Avedisian School of Medicine.
• Paula P. Schnurr, Ph.D. — Executive Director, National Center for PTSD, White River Junction VA Medical Center; Professor of Psychiatry, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire.

Institutional Contact & Resource Center:
Executive Division, National Center for PTSD (116D), VA Medical Center, 215 North Main Street, White River Junction, VT 05009, USA.
Official Web Repository: https://www.ptsd.va.gov

4. Purpose

The primary clinical and scientific purpose of the PCL-5 is to quantify, standardize, and monitor posttraumatic stress symptomatology in adults exposed to one or more traumatic life events satisfying DSM-5 Criterion A. Following the release of the DSM-5 in 2013, the diagnostic definition of PTSD underwent foundational conceptual realignments: the diagnostic architecture shifted from a three-cluster taxonomy (Intrusion, Avoidance/Numbing, and Hyperarousal) under DSM-IV to an expanded four-cluster structural framework (Intrusion, Avoidance, Negative Alterations in Cognitions and Mood, and Alterations in Arousal and Reactivity). In consequence, the widely deployed earlier versions of the instrument—the PCL-Military (PCL-M), PCL-Civilian (PCL-C), and PCL-Specific (PCL-S)—became obsolete. The PCL-5 was engineered to operationalize these refined diagnostic boundaries, integrating newly identified symptom manifestations while preserving maximal continuity with legacy psychometric databases.

The instrument fulfills three principal operational functions across diverse healthcare, forensic, and scientific environments:

• Screening and Triage: The PCL-5 serves as an efficient frontline self-report screening device in primary care, emergency medical settings, military reintegration centers, and disaster relief zones. Utilizing validated empirical cut-points, clinical systems can identify patients who exhibit elevated symptom profiles requiring comprehensive diagnostic interviews.
• Provisional Diagnostic Evaluation: When structured psychiatric interviews like the CAPS-5 cannot be immediately administered due to clinical resource limitations or epidemiological scale, the PCL-5 can be scored using a symptom-endorsement threshold algorithm (mapping item scores ≥ 2 onto DSM-5 diagnostic criteria rules) to establish a provisional or presumptive diagnosis of PTSD.
• Longitudinal Symptom Tracking and Measurement-Based Care: In ongoing psychological or pharmacotherapeutic interventions—such as Cognitive Processing Therapy (CPT), Prolonged Exposure (PE), or Eye Movement Desensitization and Reprocessing (EMDR)—the continuous scale (0 to 80) affords high sensitivity to change over time, enabling clinicians to assess treatment efficacy, evaluate reliable change metrics, and modify intervention plans proactively.

Beyond tertiary military and veteran healthcare systems, the PCL-5 is broadly validated across surviving populations of interpersonal violence, intimate partner abuse, occupational trauma in first responders, catastrophic industrial and vehicular accidents, and acute medical traumas (such as intensive care unit survivorship and major burn injuries). The instrument balances theoretical breadth with practical brevity, requiring only 5 to 10 minutes for full completion.

5. Psychological Construct

The psychological construct evaluated by the PCL-5 is posttraumatic stress psychopathology, an intricate neuropsychological and emotional syndrome that develops following exposure to actual or threatened death, serious injury, or sexual violence. The construct is dimensional, conceptualized along a spectrum ranging from subclinical, transient stress reactions to chronic, disabling neuropsychiatric syndromes characterized by severe operational distress and functional impairment. Under the DSM-5 nosological structure, the PCL-5 measures four distinct yet interrelated symptom clusters:

Criterion B: Intrusion Symptoms (Items 1–5)

Intrusion symptoms capture the involuntary, recurrent re-experiencing of the traumatic event across sensory, perceptual, and cognitive modalities. This domain evaluates:

• Recurrent, involuntary, and intrusive distressing memories of the traumatic experience (Item 1).
• Recurrent distressing dreams where dream content or affect is directly tied to the traumatic event (Item 2).
• Dissociative reactions along a continuum from fleeting sensory flashbacks to complete loss of current situational awareness, wherein the individual feels or acts as if the trauma were recurring in real time (Item 3).
• Intense or prolonged psychological distress upon encountering internal or external cues that symbolize or resemble an aspect of the trauma (Item 4).
• Marked physiological reactivity to traumatic reminders, including autonomic nervous system activation characterized by tachycardia, diaphoresis, respiratory dysregulation, and peripheral vasoconstriction (Item 5).

Criterion C: Avoidance Symptoms (Items 6–7)

Persistent behavioral and cognitive avoidance reflects active, effortful strategies deployed to blunt or escape trauma-related affect and conditioned fear stimuli. This construct encapsulates:

• Cognitive and affective avoidance: Conscious efforts to suppress, avoid, or compartmentalize distressing memories, thoughts, ruminations, or feelings associated with the traumatic incident (Item 6).
• Behavioral avoidance: Deliberate evasion of external reminders—encompassing specific people, physical locations, conversations, social activities, sensory stimuli, or objects—that evoke intrusive recall of the trauma (Item 7).

Criterion D: Negative Alterations in Cognitions and Mood (Items 8–14)

This cluster represents one of the most substantial conceptual expansions introduced in the DSM-5, reflecting structural alterations in cognitive schemas, social relatedness, and baseline affective experience:

• Trauma-related dissociative amnesia: Inability to recall key features of the traumatic event, distinct from organic amnesia, traumatic brain injury (TBI), or substance intoxication (Item 8).
• Distorted cognitive appraisals: Persistent, exaggerated negative expectations or overgeneralized beliefs regarding oneself, others, or the world at large (e.g., “I am irreparably damaged,” “No human being can be trusted,” “The world is entirely lethal”) (Item 9).
• Distorted etiologic blame: Pervasive cognitive distortions causing individuals to assign inappropriate blame to themselves or others for the occurrence of the trauma or its subsequent consequences (Item 10).
• Persistent negative emotional states: Chronic experiences of terror, horror, pathological guilt, debilitating shame, or intense rage (Item 11).
• Anhedonia: Markedly diminished interest or participation in previously significant vocational, recreational, or interpersonal activities (Item 12).
• Social detachment: Subjective sensations of profound alienation, estrangement, or emotional detachment from family, peers, and social networks (Item 13).
• Emotional numbing / constricted affect: Persistent inability to experience positive emotional states, such as loving feelings, joy, satisfaction, affection, or contentment (Item 14).

Criterion E: Alterations in Arousal and Reactivity (Items 15–20)

Alterations in arousal and reactivity reflect chronic dysregulation of the autonomic nervous system and neuroendocrine stress pathways, operationalized through behavioral, motoric, and attentional disturbances:

• Irritability and aggression: Volatile emotional control manifesting as irritable behavior, sudden verbal outbursts, or unprovoked physical aggression (Item 15).
• Reckless or self-destructive behavior: Maladaptive risk-taking, dangerous driving, substance misuse, or reckless actions executed without adequate consideration of physical harm (Item 16).
• Hypervigilance: Pervasive sensory scanning, excessive wariness, and elevated situational guarding against prospective environmental threats (Item 17).
• Exaggerated startle response: Heightened motoric and somatic reactivity to sudden, unexpected acoustic, visual, or tactile stimuli (Item 18).
• Attentional impairment: Inability to sustain focus, follow complex tasks, or direct working memory due to intrusive mental interference (Item 19).
• Sleep architecture disturbance: Insomnia, mid-sleep awakenings, early morning awakenings, or non-restorative sleep patterns linked to sustained hyperarousal (Item 20).

6. Theoretical Framework

The conceptual underpinning of the PCL-5 is deeply rooted in several foundational paradigms within modern clinical psychology and cognitive neuroscience. Rather than viewing PTSD merely as an isolated collection of diagnostic codes, contemporary psychopathology conceptualizes the syndrome through intersecting cognitive, behavioral, and neurobiological models.

Emotional Processing Theory

Originally formulated by Edna B. Foa and Michael J. Kozak (1986) and later refined by Foa, Huppert, and Cahill (2006), Emotional Processing Theory posits that PTSD is driven by pathological fear networks stored in long-term memory. These fear networks incorporate three distinct categories of information: (a) stimulus information regarding the traumatic environment (e.g., specific sights, sounds, smells); (b) verbal, motoric, and physiological response information (e.g., extreme panic, tachycardia, escape attempts); and (c) interpretive meaning elements linking stimuli to pervasive threat (e.g., “I will die,” “The world is entirely lethal”). In individuals with PTSD, these networks are excessively broad, highly organized, and easily activated by minor environmental cues. The PCL-5 directly indexes fear network activation through Criterion B (intrusive sensory retrieval), attempts at network suppression via Criterion C (avoidance), and persistent somatic alarm through Criterion E (hyperarousal).

Cognitive Model of PTSD

The cognitive model formulated by Anke Ehlers and David M. Clark (2000) provides an essential framework for understanding Criterion D. Ehlers and Clark argue that PTSD develops and becomes chronic when individuals process traumatic information in a manner that produces a sense of current, ongoing threat. This persistent sense of threat arises from two major mechanisms:

1. Excessively negative appraisals of the trauma and its aftermath: Survivors interpret their emotional responses or post-event difficulties catastrophically (e.g., interpreting traumatic amnesia as evidence of permanent cognitive ruin, or viewing emotional numbness as moral failure).
2. Nature of the trauma memory: Traumatic memories are poorly contextualized and weakly integrated into the autobiographical memory base. Consequently, they are triggered automatically by perceptual cues without intentional recall, accompanied by a compelling sense of “nowness.” The PCL-5 measures both the distorted catastrophic appraisals (Items 9 and 10) and the disjointed retrieval characteristics of the trauma memory (Items 1 and 8).

Dual Representation Theory

Advanced by Chris R. Brewin and colleagues (1996, 2010), Dual Representation Theory proposes that human memory systems encode trauma across two dissociated processing streams: Verbally Accessible Memory (VAM) and Situationally Accessible Memory (SAM). VAM representations are integrated into the personal life narrative, verbally retrievable, and contextually bounded. In contrast, SAM representations consist of low-level perceptual and somatic impressions stored within subcortical circuits (particularly the amygdala) without contextual temporal indexing. When triggered, SAM representations induce vivid, visceral re-experiencing (PCL-5 Items 1–5). Recovery involves translating SAM sensory fragments into coherent VAM narratives, an emotional-cognitive transition tracked quantitatively by longitudinal reductions in PCL-5 subscale scores.

Neurobiological Systems Framework

Neuroimaging and psychophysiological models demonstrate that the clinical features captured by the PCL-5 reflect functional and structural abnormalities within fronto-limbic neural networks. Specifically, PTSD involves hyper-responsivity within the amygdala and dorsal anterior cingulate cortex, alongside hypo-activation within the ventromedial prefrontal cortex (vmPFC), leading to a failure of top-down inhibitory control over conditioned fear. Concurrently, volumetric reductions and functional compromises within the hippocampus disrupt environmental context encoding, preventing the individual from recognizing that current stimuli do not represent past traumatic events. This neurobiological dysregulation sustains the hypervigilance (Item 17), exaggerated startle (Item 18), and persistent autonomic arousal (Item 5) assessed by the PCL-5.

7. Validity

The construct, criterion, convergent, and discriminant validity of the PCL-5 have been rigorously validated across dozens of independent clinical, epidemiological, and military cohorts worldwide.

Convergent and Concurrent Validity

Validation studies demonstrate strong convergent validity when PCL-5 scores are benchmarked against gold-standard clinician-administered diagnostic interviews. In the seminal psychometric evaluation conducted by Bovin et al. (2016) in a cohort of 468 military veterans, the PCL-5 total score demonstrated a high correlation with the CAPS-5 total symptom severity score (r = .85). Similarly, Blevins, Weathers, Davis, Witte, and Domino (2015) evaluated trauma-exposed undergraduate university students and demonstrated substantial convergent correlations with legacy measures of PTSD, including the PCL-Specific for DSM-IV (r = .84 to .87) and the Trauma Symptom Checklist-40 (r = .74 to .79).

Furthermore, the PCL-5 correlates strongly with instruments measuring theoretically allied psychological constructs:

• Depressive symptoms as measured by the Patient Health Questionnaire-9 (PHQ-9): r = .73 to .77.
• Generalized anxiety as measured by the Generalized Anxiety Disorder-7 (GAD-7): r = .74 to .76.
• Functional impairment measured via the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0): r = .58 to .65.

Discriminant Validity

Discriminant validity is supported by lower correlations with measures of unrelated constructs. For example, correlations between the PCL-5 and measures of somatic complaints without psychological origin, generalized social desirability, or unrelated personality dimensions (such as extraversion or conscientiousness) generally remain modest to weak (r = .15 to .32). While the PCL-5 correlates moderately to strongly with depression and generalized anxiety scales—reflecting the well-known clinical comorbidity and shared general distress (neuroticism) underlying internalizing disorders—CFA modeling confirms that the PCL-5 latent factors remain distinct from latent depression and general anxiety constructs.

Criterion-Related and Diagnostic Accuracy (ROC Analysis)

Using Receiver Operating Characteristic (ROC) analyses against the CAPS-5 diagnostic determination, studies demonstrate high diagnostic performance, with Area Under the Curve (AUC) values regularly ranging between .89 and .95:

• Bovin et al. (2016) Veteran Sample: A cut-point between 31 and 33 yielded optimal diagnostic utility. Specifically, a cutoff score of 33 yielded a sensitivity of .88, a specificity of .69, a positive predictive value (PPV) of .66, and a negative predictive value (NPV) of .89 in a veteran mental health clinic. A slightly more conservative cutoff of 31 optimized sensitivity (.93) with acceptable specificity (.65) for broad screening triage.
• Wortmann et al. (2016) Active-Duty Military Sample: Identified an optimal threshold range of 31 to 33, producing sensitivity and specificity values exceeding .85 and .80, respectively.
• Civilian and Specialized Samples: Some studies examining primary care patients or student populations have observed cutoffs ranging from 28 to 38, depending on the base rate of trauma exposure and whether maximizing sensitivity (to avoid false negatives) or specificity (to prevent over-diagnosis) was the primary clinical goal.

8. Reliability

The PCL-5 displays high reliability across diverse demographic groups, cultural contexts, languages, and settings.

Internal Consistency

Internal consistency estimates for the total scale score are consistently high across empirical studies:

• Blevins et al. (2015): Cronbach’s alpha for the total score was α = .94 in trauma-exposed civilian university samples, with subscale coefficients of α = .85 (Criterion B), α = .85 (Criterion C), α = .86 (Criterion D), and α = .83 (Criterion E).
• Bovin et al. (2016): Observed an overall alpha of α = .96 in military veterans, with subscale alphas ranging from .81 to .91.
• Sveen et al. (2016): Cross-cultural and translated adaptations (e.g., Swedish, German, Chinese, Arabic) show internal consistency values ranging from α = .92 to .97 for the total score and α = .75 to .90 for individual symptom clusters.
• McDonald’s Omega: To address well-known psychometric limitations of Cronbach’s alpha, investigators have calculated McDonald’s omega (ω), with composite reliability estimates regularly falling between ω = .95 and .97.

Test-Retest Reliability and Temporal Stability

Temporal stability assessments have confirmed that the PCL-5 measures a stable clinical construct while remaining sensitive to genuine therapeutic change:

• Short-interval retest (1 to 7 days): In stable outpatient or student samples prior to intervention, test-retest correlations range between r = .82 and .88, indicating robust stability without significant test fatigue or practice artifacts (Blevins et al., 2015).
• Intermediate retest (30 days): Demonstrates stability coefficients around r = .84 in non-treatment cohorts.

Measurement Error and Clinical Change Metrics

Establishing the Standard Error of Measurement (SEM) and the Reliable Change Index (RCI) is essential for evidence-based practice:

• Standard Error of Measurement (SEM): Psychometric studies estimate the SEM of the total PCL-5 score to be approximately 3.1 to 3.5 points.
• Minimum Detectable Change (MDC): At the 95% confidence interval, the MDC is estimated between 8.6 and 9.7 points.
• Clinically Meaningful Change: Consensus recommendations from the National Center for PTSD designate a 5 to 10 point reduction as reflecting reliable clinical improvement, while an absolute reduction of at least 10 points represents a clinically meaningful therapeutic response, confirming that observed improvements are not attributable to measurement error.

9. Factor Analysis

The latent dimensionality of the PCL-5 has been one of the most vigorously investigated topics in contemporary psychometrics. While the instrument was explicitly written to correspond with the four-factor diagnostic model mandated by the DSM-5, extensive exploratory (EFA) and confirmatory factor analyses (CFA) have evaluated competing structural models.

The Four-Factor DSM-5 Baseline Model

The official diagnostic architecture presumes four distinct, correlated latent factors: (1) Intrusion (items 1–5), (2) Avoidance (items 6–7), (3) Negative Alterations in Cognitions and Mood (items 8–14), and (4) Alterations in Arousal and Reactivity (items 15–20). When tested via CFA, this model generally displays acceptable, though occasionally suboptimal, goodness-of-fit indices:

• Comparative Fit Index (CFI) ≈ .89 – .92
• Tucker-Lewis Index (TLI) ≈ .88 – .91
• Root Mean Square Error of Approximation (RMSEA) ≈ .065 – .080
• Standardized Root Mean Square Residual (SRMR) ≈ .048 – .058

Alternative Latent Trait Architectures

Because the 20 symptoms often exhibit fine-grained empirical dissociations, psychometric researchers proposed and evaluated several alternative factor models to better account for shared variance:

• Six-Factor Anhedonia Model (Liu et al., 2014): Separates Criterion D into cognitive negative affect and anhedonic symptoms, creating six factors: (1) Intrusion, (2) Avoidance, (3) Negative Cognitions and Mood, (4) Anhedonia (items 12–14), (5) Dysphoric Arousal (items 19–20), and (6) Anxious Arousal (items 15–18).
• Six-Factor Externalizing Model (Tsai et al., 2015): Isolates externalizing behaviors from general arousal, yielding: (1) Intrusion, (2) Avoidance, (3) Negative Alterations in Cognitions and Mood, (4) Anxious Arousal, (5) Dysphoric Arousal, and (6) Externalizing Behaviors (items 15–16: irritability, aggression, risk-taking).
• Seven-Factor Hybrid Model (Armour et al., 2015): Combines the divisions of both the Anhedonia and Externalizing models, producing seven discrete latent dimensions:
  1. Intrusion (Items 1–5)
  2. Avoidance (Items 6–7)
  3. Negative Affect (Items 8–11)
  4. Anhedonia (Items 12–14)
  5. Dysphoric Arousal (Items 19–20: concentration, sleep)
  6. Anxious Arousal (Items 17–18: hypervigilance, exaggerated startle)
  7. Externalizing Behaviors (Items 15–16: anger, reckless acts)

Empirical Model Comparison and Invariance

Multiple large-scale comparative CFA studies (e.g., Armour et al., 2015; Bovin et al., 2016; Wortmann et al., 2016) have established that the Armour 7-Factor Hybrid Model routinely demonstrates statistically superior fit over the DSM-5 four-factor model across diverse cohorts (CFI > .95, TLI > .94, RMSEA ≤ .045, lower Bayesian Information Criterion [BIC] values). Furthermore, rigorous multi-group confirmatory factor analysis (MGCFA) has confirmed metric and scalar measurement invariance across gender, civilian versus military status, and diverse racial and ethnic groups, proving that the item factor loadings and intercepts are statistically equivalent across disparate demographic populations.

10. Instrument / Measurement Tool

• Instrument Name: PTSD Checklist for DSM-5 (PCL-5).
• Primary Developer / Institution: Frank W. Weathers, Brett T. Litz, Terence M. Keane, Pamela A. Palmieri, Brian P. Marx, and Paula P. Schnurr; National Center for PTSD.
• Construct Assessed: Severity and diagnostic presence of Posttraumatic Stress Disorder symptoms based on DSM-5 criteria.
• Format / Administration: Self-administered paper-and-pencil or computerized self-report questionnaire. May be administered independently or paired with a trauma index (e.g., the Life Events Checklist for DSM-5, LEC-5) or Criterion A symptom-linkage prompt.
• Item Count: 20 items.
• Target Respondent Population: Adults (aged 18 and older) who have experienced, witnessed, or been confronted with traumatic life events. (Can be utilized with older adolescents under clinical supervision, though pediatric adaptations like the UCLA PTSD Reaction Index are preferred for younger youth).
• Estimated Completion Time: 5 to 10 minutes.
• Recall Period: Past month (standard baseline version); past week (modified version used for frequent weekly clinical outcome monitoring).
• Response Scale (5-point Likert scale):
  • 0 = Not at all
  • 1 = A little bit
  • 2 = Moderately
  • 3 = Quite a bit
  • 4 = Extremely
• Subscale / Cluster Groupings:
  • Criterion B (Intrusion): Items 1, 2, 3, 4, 5 (Score range: 0–20)
  • Criterion C (Avoidance): Items 6, 7 (Score range: 0–8)
  • Criterion D (Negative Alterations in Cognitions and Mood): Items 8, 9, 10, 11, 12, 13, 14 (Score range: 0–28)
  • Criterion E (Alterations in Arousal and Reactivity): Items 15, 16, 17, 18, 19, 20 (Score range: 0–24)
• Scoring Algorithms:
  • Continuous Total Severity Score: Calculated by summing all 20 individual item responses. Total score ranges from 0 to 80, where higher scores reflect greater PTSD symptom severity.
  • DSM-5 Symptom Endorsement / Provisional Diagnostic Rule: An item is treated as an endorsed symptom if it is rated 2 (“Moderately”) or higher. A provisional PTSD diagnosis requires fulfilling the DSM-5 diagnostic rule:
    • At least 1 Criterion B symptom (Items 1–5)
    • At least 1 Criterion C symptom (Items 6–7)
    • At least 2 Criterion D symptoms (Items 8–14)
    • At least 2 Criterion E symptoms (Items 15–20)
  • Diagnostic Cutoff Threshold: A continuous total score cut-point of 31 to 33 indicates clinically significant posttraumatic stress symptomatology requiring detailed clinical interview and diagnostic workup.
  • Mean Item Scores: Subscale mean scores can be obtained by dividing each cluster sum by its corresponding number of items, yielding a metric ranging from 0 to 4 that aids cross-cluster comparison.
• Reverse-Scored Items: None. All items are positively keyed toward symptom severity.

11. Permissions & Fee and Test Year

The PCL-5 was developed by federal employees of the United States Government within the National Center for PTSD, an operating agency of the Department of Veterans Affairs, and was officially released to the medical and scientific community in 2013 concurrent with the publication of the DSM-5.

Licensing, Availability, and Fees:

• Public Domain: As a work produced by federal employees in the course of their official duties, the PCL-5 is in the public domain. There are no royalty fees, licensing costs, or purchase charges associated with accessing or utilizing the instrument.
• Clinical and Research Permissions: Clinicians, researchers, health organizations, and public health entities are permitted to download, reproduce, administer, and integrate the PCL-5 into electronic health record (EHR) systems without requesting formal written permission from the authors or the National Center for PTSD.
• Commercial and Modification Restrictions: While the measure is freely accessible, users may not sell the instrument, copyright its original text, or alter the standardized wording, response formats, or item order, as doing so invalidates its established psychometric properties.
• Official Source: Scale materials, scoring manuals, translated versions, and administrative guidelines are maintained by the National Center for PTSD at www.ptsd.va.gov.

12. References

Below is a curated list of seminal academic references documenting the development, psychometric properties, factor structure, and clinical application of the PCL-5, formatted in APA 7th edition:

• Armour, C., Müllerová, J., & Elhai, J. D. (2015). A systematic literature review of PTSD’s latent structure in the Diagnostic and Statistical Manual of Mental Disorders: DSM-IV to the DSM-5. Clinical Psychology Review, 44, 60–74. https://doi.org/10.1016/j.cpr.2015.12.003
• Blevins, C. A., Weathers, F. W., Davis, M. T., Witte, T. K., & Domino, J. L. (2015). The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): Development and initial psychometric evaluation. Journal of Traumatic Stress, 28(6), 489–498. https://doi.org/10.1002/jts.22059
• Bovin, M. J., Marx, B. P., Weathers, F. W., Gallagher, M. W., Rodriguez, P., Schnurr, P. P., & Keane, T. M. (2016). Psychometric properties of the PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders–Fifth Edition (PCL-5) in veterans. Psychological Assessment, 28(11), 1379–1391. https://doi.org/10.1037/pas0000254
• Brewin, C. R., Dalgleish, T., & Joseph, S. (1996). A dual representation theory of posttraumatic stress disorder. Psychological Review, 103(4), 670–686. https://doi.org/10.1037/0033-295X.103.4.670
• Cohen, J., Weathers, F. W., Litz, B. T., Keane, T. M., Palmieri, P. A., Marx, B. P., & Schnurr, P. P. (2015). Preliminary evaluation of the psychometric properties of the PTSD Checklist for DSM-5 (Conference presentation). International Society for Traumatic Stress Studies 31st Annual Meeting, New Orleans, LA. https://doi.org/10.12140/2.1.4448.5444
• Ehlers, A., & Clark, D. M. (2000). A cognitive model of posttraumatic stress disorder. Behaviour Research and Therapy, 38(4), 319–345. https://doi.org/10.1016/S0005-7967(99)00123-0
• Foa, E. B., & Kozak, M. J. (1986). Emotional processing of fear: Exposure to corrective information. Psychological Bulletin, 99(1), 20–35. https://doi.org/10.1037/0033-2909.99.1.20
• Liu, P., Wang, L., Cao, C., Wang, R., Zhang, J., Zhang, B., Wu, Q., Li, H., & Elhai, J. D. (2014). The underlying dimensions of DSM-5 posttraumatic stress disorder symptoms in an epidemiological sample of Chinese earthquake victims. Journal of Anxiety Disorders, 28(4), 345–351. https://doi.org/10.1016/j.janxdis.2014.03.008
• Sveen, J., Bondjers, K., & Willebrand, M. (2016). Psychometric properties of the PTSD Checklist for DSM-5 and the Lifetime Incidence of Traumatic Events sheet in a Swedish community sample. European Journal of Psychotraumatology, 7(1), 30165. https://doi.org/10.3402/ejpt.v7.30165
• Tsai, J., Harpaz-Rotem, I., Armour, C., Southwick, S. M., Krystal, J. H., & Pietrzak, R. H. (2015). Dimensional structure of DSM-5 posttraumatic stress disorder symptoms: Results from the National Health and Resilience in Veterans Study. The Journal of Clinical Psychiatry, 76(5), 546–553. https://doi.org/10.4088/JCP.14m09091
• Weathers, F. W., Litz, B. T., Keane, T. M., Palmieri, P. A., Marx, B. P., & Schnurr, P. P. (2013). The PTSD Checklist for DSM-5 (PCL-5). Scale available from the National Center for PTSD at www.ptsd.va.gov.
• Wortmann, J. H., Jordan, A. H., Weathers, F. W., Resick, P. A., Dondanville, K. A., Hall-Clark, B., Foa, E. B., Young-McCaughan, S., Mintz, J., Litz, B. T., & Peterson, A. L. (2016). Psychometric analysis of the PTSD Checklist-5 (PCL-5) among treatment-seeking military service members. Psychological Assessment, 28(11), 1392–1403. https://doi.org/10.1037/pas0000260

13. Items of the Scale (Questionnaire)